Regulators aren’t expected to pass judgment on the $69 billion Aetna purchase until late this year, but CVS issued the debt this week to avoid the risk that interest rates continue to rise.

from Kaiser Health News http://ift.tt/2tlZO69

Related Posts:

0 comments:

Post a Comment

Popular Posts